Affiliation:
1. University of Utah, Salt Lake City, UT, USA
Abstract
Objective: To describe blood pressure and glycemic control by racial/ethnic group in the US Community Health Center (CHC) patient population, and whether center characteristics, proxying for higher resource levels and better quality of care, were associated with greater rates of controlled cardiometabolic conditions. Methods: Data came from the Uniform Data System, representing aggregate patient clinical data for individual health centers in 2019. Descriptive analyses were conducted weighting by health center patient populations to produce race-specific national rates of blood pressure and glycemic control, and linear regression is used to test whether cardiometabolic control rates varied by center characteristics. Results: Hypertension was controlled for 67.2% of non-Hispanic White, 66.9% of Hispanic, and 56.7% of non-Hispanic Black patients. Diabetes was controlled for 70.7% of non-Hispanic White, 65.7% of Hispanic, and 66.1% of non-Hispanic Black patients. The rate of blood pressure control was 2.54 to 3.99 percentage points higher across racial/ethnic groups in health centers that adopted a patient-centered medical home (PCMH) model of care relative to non-PCMH centers, while glycemic control was 1.08 to 2.27 pp. higher as a function of PCMH certification. Results for other center characteristics did not show consistent patterns across racial groups or outcomes. Conclusion: This study documented racial and ethnic health disparities in the CHC patient population after major expansion of the CHC program. CHCs with PCMH certification have improved clinical outcomes among patients with hypertension and diabetes across racial/ethnic groups relative to centers without this certification.
Funder
National Institutes of Health
Reference42 articles.
1. Prevalence of Diabetes by Race and Ethnicity in the United States, 2011-2016
2. Centers for Disease Control and Prevention. Summary health statistics: National health interview survey. 2018. Accessed April 2021. ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2018/srvydesc.pdf
3. Mortality in type 2 diabetes mellitus: magnitude of the evidence from a systematic review and meta-analysis
4. Kung HC, Xiu J. Hypertension-Related Mortality in the United States, 2000-2013. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2015. https://www.google.com/books/edition/Hypertension_related_Mortality_in_the_Un/dEY8nM-u3W4C?hl=en&gbpv=1